Literature DB >> 17587428

Seasonality of the onset of symptoms, tuberculin test anergy and Kveim positive reaction in a large cohort of patients with sarcoidosis.

Sevtap Sipahi Demirkok1, Metin Basaranoglu, Elif Coker, Tuncer Karayel.   

Abstract

BACKGROUND AND OBJECTIVES: Sarcoidosis is a systemic granulomatous disease of unknown aetiology and pathogenesis. This study evaluated the seasonal variation in the onset of symptoms, Tuberculin anergy and Kveim positive reaction in a cohort of 492 patients with sarcoidosis and in a subgroup of 248 patients with known Kveim test responses.
METHODS: The medical records of 492 patients with sarcoidosis were retrospectively reviewed. Roger's test for cyclic variation was used to assess the statistical significance of the observed seasonal variation.
RESULTS: For all sarcoidosis patients (n = 492) the onset of symptoms was most frequent in spring (61.8%) and least frequent in summer (31.7%) (P < 0.001). For patients with Tuberculin anergy (n = 364) the onset of symptoms was most frequent in spring and least frequent in autumn (P < 0.001); there was no seasonal variation among Tuberculin positive patients (n = 128). Of those patients with a Kveim test result (n = 248), the onset of symptoms was most frequent in spring and least frequent in summer (P < 0.001); there was no seasonal variation for patients with a negative Kveim results (n = 50 patients).
CONCLUSIONS: The onset of the symptoms was most frequent in spring and least frequent in the second half of the year (summer or autumn) in patients with sarcoidosis, Tuberculin anergy and a positive Kveim reaction. The significance of this finding in relation to aetiology and clinical utility needs to be further assessed.

Entities:  

Mesh:

Year:  2007        PMID: 17587428     DOI: 10.1111/j.1440-1843.2007.01062.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  7 in total

Review 1.  How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants.

Authors:  Manuel Ramos-Casals; Belchin Kostov; Pilar Brito-Zerón; Antoni Sisó-Almirall; Robert P Baughman
Journal:  Lung       Date:  2019-06-12       Impact factor: 2.584

Review 2.  Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.

Authors:  P Ungprasert; C S Crowson; E L Matteson
Journal:  Reumatismo       Date:  2017-05-22

3.  Smoking, obesity and risk of sarcoidosis: A population-based nested case-control study.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Respir Med       Date:  2016-10-11       Impact factor: 3.415

4.  Seasonal variation in incidence of sarcoidosis: a population-based study, 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Thorax       Date:  2016-08-18       Impact factor: 9.139

5.  Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL.

Authors:  Kyra A Oswald-Richter; Dia C Beachboard; Erin H Seeley; Susamma Abraham; Bryan E Shepherd; Cathy A Jenkins; Daniel A Culver; Richard M Caprioli; Wonder P Drake
Journal:  J Clin Immunol       Date:  2012-05-03       Impact factor: 8.317

6.  Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis.

Authors:  Kyra A Oswald-Richter; Daniel A Culver; Charlene Hawkins; Rana Hajizadeh; Susamma Abraham; Bryan E Shepherd; Cathy A Jenkins; Marc A Judson; Wonder P Drake
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

Review 7.  Environmental Risk Factors for Sarcoidosis.

Authors:  Marc A Judson
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.